Aspira Women's Health Revenue and Competitors
Estimated Revenue & Valuation
- Aspira Women's Health's estimated annual revenue is currently $16.4M per year.
- Aspira Women's Health's estimated revenue per employee is $155,000
Employee Data
- Aspira Women's Health has 106 Employees.
- Aspira Women's Health grew their employee count by -6% last year.
Aspira Women's Health's People
Name | Title | Email/Phone |
---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | CEO, President & Director | Reveal Email/Phone |
3 | Director Corporate Communications & Chief Staff | Reveal Email/Phone |
4 | SVP and Chief Financial Officer | Reveal Email/Phone |
5 | VP Research and Development | Reveal Email/Phone |
6 | SVP, Commercial | Reveal Email/Phone |
7 | SVP Human Resources | Reveal Email/Phone |
8 | VP Sales and Professional Relations | Reveal Email/Phone |
9 | Head Corporate Strategy, Reimbursement and Managed Care | Reveal Email/Phone |
10 | SVP, Commercial Strategy and Operations | Reveal Email/Phone |
Aspira Women's Health Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.2M | 1 | -80% | N/A | N/A |
#2 | $4.3M | 28 | 8% | N/A | N/A |
#3 | $9.8M | 66 | -11% | N/A | N/A |
#4 | $1.4M | 9 | 350% | N/A | N/A |
#5 | $16.6M | 107 | -23% | N/A | N/A |
#6 | $4.5M | 29 | -22% | N/A | N/A |
#7 | $1.7M | 11 | 57% | N/A | N/A |
#8 | $2.3M | 15 | -6% | N/A | N/A |
#9 | $0.3M | 4 | -43% | N/A | N/A |
#10 | $4M | 26 | 0% | N/A | N/A |
What Is Aspira Women's Health?
Aspira Women's Health Inc. (formerly known as Vermillion, Inc. Nasdaq: VRML) is transforming women's health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1®plus combines our FDA-cleared products OVA1® and OVERA® to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiXSM testing offers both targeted and a more comprehensive genetic testing options with a gynecologic focus. Our focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.
keywords:N/AN/A
Total Funding
106
Number of Employees
$16.4M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aspira Women's Health News
InvestorsObserver is giving Aspira Women's Health Inc (AWH) an Analyst Rating Rank of 73, meaning AWH is ranked higher by analysts than 73%...
Aspira Women's Health Inc. (NASDAQ:AWH) Short Interest Update. Posted by admin on Apr 16th, 2022. Share on Twitter Share on Facebook Share on LinkedIn Share...
Aspira Women's Health is particularly focused on closing the ethnic disparity gap in ovarian cancer risk assessment and developing solutions for...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 106 | 9% | N/A |
#2 | $30M | 111 | 5% | N/A |
#3 | $43.6M | 133 | 9% | N/A |
#4 | $21.6M | 140 | N/A | N/A |
#5 | $30.7M | 155 | 9% | N/A |